ARTICLE | Company News
BioCancell, Pro-Pharmaceuticals deal
May 26, 2008 7:00 AM UTC
The companies partnered to develop BioCancell’s BC-819 plasmid with Pro-Pharmaceuticals’ Davanat delivery system to treat cancer. Pro-Pharmaceuticals will conduct and fund in vivo and in vitro tests...